K2 Capital Acquisition (KTWO) vs OraSure Technologies (OSUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
OraSure Technologies is the larger company by market cap ($257.3 million vs $201.8 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KTWO | OSUR |
|---|---|---|
| Share price | $10.07 | $3.73 |
| Market cap | $201.81M | $257.25M |
| 1-day change | -0.20% | -1.06% |
| YTD return | — | +54.13% |
| 1-year return | — | +18.04% |
| 5-year return | — | -64.51% |
| EPS (TTM) | — | $-0.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.10 | $4.58 |
| 52-week low | $9.84 | $2.08 |
| Distance from 52-week high | -0.30% | -18.56% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +7.24% |
| Average volume | 29.51K | 480.98K |
| Shares outstanding | 14.13M | 68.97M |
| Employees | — | 500 |
| Sector | Financial Services | Healthcare |
| Industry | Shell Companies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: K2 Capital Acquisition in Financial Services and OraSure Technologies in Healthcare.
About K2 Capital Acquisition
KTWO stock →K2 Capital Acquisition Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the physical AI or energy transition sectors.
Financial Services · Shell Companies
About OraSure Technologies
OSUR stock →OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
Healthcare · Medical Instruments & Supplies · 500 employees
KTWO vs OSUR FAQ
Which is bigger, K2 Capital Acquisition or OraSure Technologies?
OraSure Technologies (OSUR) is larger, with a market capitalization of $257.25M compared with $201.81M for K2 Capital Acquisition (KTWO).
Are K2 Capital Acquisition and OraSure Technologies in the same industry?
No. K2 Capital Acquisition is in the Financial Services sector, while OraSure Technologies is in Healthcare.